Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CYCLIC PEPTIDE IMMUNOMODULATORS
Document Type and Number:
WIPO Patent Application WO/2022/221284
Kind Code:
A3
Abstract:
The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PDL1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.

More Like This:
JP6404213Phospholamban protein phosphatase 1-mediated dephosphorylation-suppressing decoy peptide {DecoyPeptidesInhibitingProteinPhosphatase1-MediatedDephosphorylationofPhospholamban}
WO/1991/013909SYNTHETIC POLYPEPTIDES
WO/2001/032848MIMIC CELLULOSE BINDING DOMAIN
Inventors:
WANG TAO (US)
Application Number:
PCT/US2022/024430
Publication Date:
December 15, 2022
Filing Date:
April 12, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BRISTOL MYERS SQUIBB CO (US)
International Classes:
C07K7/08; C07K14/705; A61K38/00
Domestic Patent References:
WO2018237153A12018-12-27
WO2020237081A12020-11-26
WO2016039749A12016-03-17
WO2021188480A12021-09-23
WO2021226460A12021-11-11
Attorney, Agent or Firm:
CALVO, Paul A. et al. (US)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: PROFILING CELL TYPES IN CIRCULATING NUCLEIC ACID LIQUID BIOPSY

Next Patent: LITHIUM RECOVERY PROCESS